This paper attempts to answer the following questions concerning the complex association between ulcerative colitis and cancer of the large bowel: (1) Which patients with ulcerative colitis are especially liable to malignant change? (2) At what stage of their disease is this change most likely to occur? (3) What sort of cancer risk does an individual patient with ulcerative colitis face? (4) Is this risk sufficient to warrant the use of prophylactic surgery ?
The cancers reported here were noted during a survey of465 patients with ulcerative colitis seen between 1952 and 1963. The early course of colitis and the long-term prognosis of this group have been reported elsewhere (Watts et al. 1966a, b) . During the survey, 14 patients were found to have cancer of the large bowel. The present paper, however, is concerned only with 8 of these patients who developed frank, invasive carcinoma during their period of follow-up by us for colitis. Patients with carcinoma-in-situ, or with cancer on referral, are excluded from present consideration.
The mortality due to cancer in our group of patients was eleven times the expected mortality among a matched sample of the general population. Cancer occurred almost exclusively in the 210 patients with total involvement of the colon and rectum by colitis: no patients with lesser involvement developed cancer. An analysis of the patients with total involvement was made, using the concept of a 'patient year' -one year of observed follow-up of an individual patient (Watts et al. 1966b ); this enabled us to evaluate the annual risk of malignancy in patients with total involvement. The annual risk in the first ten years of colitis is less than 0 5% but, after twenty years of colitic symptoms, the annual risk rises to nearly 6%. It must be stressed that this 6 % is a risk which the patient faces every year. The overall or cumulative risk during a period of twenty-five years is, of course, much higher and in our patients this cumulative risk, over twenty-five years of colitic symptoms, was no less than 42 %. We would therefore recommend prophylactic proctocolectomy to any patient with total involvement after ten years' colitic symptoms on the basis of cancer prevention alone. Moreover, we have previously proposed proctocolectomy for all patients with total involvement, whatever their duration of symptoms (de Dombal et al. 1965 ); a further detailed analysis of many hundreds of patient years has shown that, for such a patient, the risks of proctocolectomy and an ileostomy life are far outweighed by the dangers of continued medical treatment.
[A fuller version of this paper will appear in the British MedicalJournal] Carcinoma of the rectum and colon is not a very common complication of ulcerative colitis: in three big series the incidence lay between 3 and 4% (Slaney & Brooke 1959 , Nefzger & Acheson 1963 , Edwards & Truelove 1964 . It has been estimated that this is about eight times that to be expected in a comparable normal population (Goldgraber et al. 1958) . Certain colitics, however, are at much greater risk than these figures suggest.
High Risk Cases From Tables 1 and 2 and other data in the literature it is reasonable to conclude that the cancer risk in idiopathic proctitis and proctosigmoiditis is no greater than that in the normal population. There is almost certainly an increased risk in disease affecting the left colon but it is small. The major risk occurs in total colitis. The duration of the colitis at the time of diagnosis of cancer in 32 consecutive cases seen at St Mark's Hospital is shown in Fig 1. It can be seen that the majority of cancers occur after the disease has been present for ten years and that few occur earlier. Other cancer series have shown a similar disease duration distribution but, unfortunately, estimates of the cumulative risk had to be based on small numbers and are consequently liable to fairly large errors.
